HIGHLIGHTS
- who: Gilda Magliacane and collaborators from the Pathology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy have published the article: Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can!, in the Journal: Cancers 2023, 15, 43. of 17/Dec/2022
- what: This investigation was intended to be a proof of concept to determine both the feasibility and the performance of local HRD testing.
- how: To further deepen the mechanisms behind HRD the authors studied the HRR pathway by using both a custom NGS panel that analyzed 21 HRR-related genes and FISH . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.